ParkerVision, Inc. (PRKR) Reaches $2.37 After 9.00% Down Move; Tandem Diabetes Care (TNDM) Shorts Raised By 14.39%

June 16, 2017 - By Richard Conner

The stock of ParkerVision, Inc. (NASDAQ:PRKR) is a huge mover today! About 372,285 shares traded or 100.00% up from the average. ParkerVision, Inc. (NASDAQ:PRKR) has declined 22.18% since June 16, 2016 and is downtrending. It has underperformed by 38.88% the S&P500.The move comes after 6 months negative chart setup for the $43.74 million company. It was reported on Jun, 16 by Barchart.com. We have $2.16 PT which if reached, will make NASDAQ:PRKR worth $3.94 million less.

Tandem Diabetes Care Incorporated (NASDAQ:TNDM) had an increase of 14.39% in short interest. TNDM’s SI was 2.84 million shares in June as released by FINRA. Its up 14.39% from 2.48M shares previously. With 283,100 avg volume, 10 days are for Tandem Diabetes Care Incorporated (NASDAQ:TNDM)’s short sellers to cover TNDM’s short positions. The SI to Tandem Diabetes Care Incorporated’s float is 11.88%. About 228,319 shares traded. Tandem Diabetes Care Inc (NASDAQ:TNDM) has declined 86.78% since June 16, 2016 and is downtrending. It has underperformed by 103.48% the S&P500.

ParkerVision, Inc. is engaged in the designing, developing and marketing of its radio frequency technologies and products. The company has market cap of $43.74 million. The Company’s business is focused on the development and marketing of its RF technologies for mobile and other wireless applications. It currently has negative earnings. The Company’s products include a modulator/demodulator component that incorporates its technologies, as well as a small number of supporting components that are used in the assembly of wireless devices.

Tandem Diabetes Care, Inc. is a medical device company. The company has market cap of $44.09 million. The Firm is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. It currently has negative earnings. The Firm makes and sells three insulin pump products, which include t:slim Insulin Delivery System , t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4).

Investors sentiment decreased to 0.8 in 2016 Q4. Its down 0.52, from 1.32 in 2016Q3. It turned negative, as 18 investors sold Tandem Diabetes Care Inc shares while 23 reduced holdings. 13 funds opened positions while 20 raised stakes. 12.06 million shares or 30.75% less from 17.41 million shares in 2016Q3 were reported. Granite Invest Ptnrs Lc accumulated 345,556 shares or 0.05% of the stock. Rhenman Ptnrs Asset Ab owns 0.1% invested in Tandem Diabetes Care Inc (NASDAQ:TNDM) for 234,000 shares. Bnp Paribas Arbitrage owns 834 shares. Goldman Sachs Grp reported 32,067 shares. Eventide Asset reported 275,000 shares. First Mercantile Tru has 14,319 shares for 0% of their portfolio. Blackrock Fund Advsr accumulated 604,834 shares. Northwestern Mutual Wealth Management Co holds 0% in Tandem Diabetes Care Inc (NASDAQ:TNDM) or 604 shares. Kcg Holdings accumulated 38,367 shares or 0% of the stock. Gradient Invs Limited Liability Corp has 141,201 shares. 1,500 were accumulated by Meeder Asset Management. Moreover, Tfs Capital Ltd Liability has 0.03% invested in Tandem Diabetes Care Inc (NASDAQ:TNDM). Keybank Natl Association Oh owns 69,537 shares. Blackrock Advsr Ltd Liability Co owns 10,400 shares for 0% of their portfolio. Blackrock Inc has invested 0% in Tandem Diabetes Care Inc (NASDAQ:TNDM).

Among 9 analysts covering Tandem Diabetes Care (NASDAQ:TNDM), 3 have Buy rating, 1 Sell and 5 Hold. Therefore 33% are positive. Tandem Diabetes Care had 17 analyst reports since August 5, 2015 according to SRatingsIntel. Zacks downgraded the stock to “Buy” rating in Friday, August 28 report. PiperJaffray downgraded Tandem Diabetes Care Inc (NASDAQ:TNDM) on Thursday, November 3 to “Neutral” rating. The rating was downgraded by Piper Jaffray on Thursday, November 3 to “Neutral”. The firm has “Outperform” rating given on Wednesday, November 2 by Wedbush. On Wednesday, November 2 the stock rating was downgraded by Stifel Nicolaus to “Hold”. The rating was downgraded by Bank of America to “Neutral” on Thursday, January 14. Zacks downgraded the stock to “Buy” rating in Thursday, August 20 report. The company was maintained on Monday, August 10 by Deutsche Bank. The firm earned “Sell” rating on Wednesday, August 5 by Zacks. The rating was upgraded by Zacks to “Hold” on Saturday, August 22.